Clareon PanOptix Pro IOLs Evaluation After Cataract Surgery
Clareon PanOptix Pro/Pro Toric Trifocal IOL
+ Phacoemulsification
Aphakia+3
+ Cataract
+ Eye Diseases
Treatment Study
Summary
Study start date: October 14, 2025
Actual date on which the first participant was enrolled.This study focuses on evaluating two types of lenses, Clareon PanOptix Pro and Clareon PanOptix Pro Toric, that are used in cataract surgery. It is intended for individuals who require cataract surgery in both eyes. Cataracts can cause blurry vision and make daily activities challenging, and these new lens options aim to improve vision quality after surgery. By understanding how these lenses perform in real-world settings, the study may help enhance treatment options for people with cataracts. Participants in the study will attend nine scheduled visits over approximately seven months. Each participant will have cataract surgery on both eyes, with the second eye's surgery taking place within 7 to 14 days after the first. The study doesn't specify particular outcomes it measures, but generally, such studies assess improvements in vision clarity and any potential side effects. The study provides valuable information regarding the effectiveness and safety of these specific intraocular lenses in improving vision after cataract surgery.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.120 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 22 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 5 locations
Wolstan & Goldberg Eye Associates
Torrance, United StatesOpen Wolstan & Goldberg Eye Associates in Google MapsMoyes Eye Center
Kansas City, United StatesCarolina Eyecare Physicians LLC
Mt. Pleasant, United StatesHouston Eye Associates
Houston, United States